Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 3/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12212883 | 0.93 | SLC1A2 (0.69) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL11657709 | 0.84 | SLC1A2 (0.60) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL28024111 | 0.83 | CA2 (0.53) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL6670789 | 0.83 | CA2 (0.63) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL29107170 | 0.83 | CHRM1 (0.67) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL29530823 | 0.83 | SLC1A2 (0.58) | SLC1A2FOLH1 | |
| SCHEMBL27930116 | 0.82 | SLC1A2 (0.62) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL6473075 | 0.81 | SLC1A2 (0.56) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL10012415 | 0.80 | SLC1A2 (0.60) | SLC1A2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL18663874 | 0.80 | SLC1A2 (0.60) | SLC1A2CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-220531545-U | Ethyl 2, 3-dicyanopropionate recovery unit | 湖北金玉兰医药科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-115677531-B | Production process of ethyl 2, 3-dicyanopropionate | 河北诚信集团有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-115677531-B | Production process of ethyl 2, 3-dicyanopropionate | 河北诚信集团有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-220531545-U | Ethyl 2, 3-dicyanopropionate recovery unit | 湖北金玉兰医药科技有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-109575006-A | A kind of diazole pyrazole amide analog derivative and its microwave attenuation materials method and application | 中南民族大学 | 2019-04-05 | — | — | CN | disclosed |
| CN-109575006-A | A kind of diazole pyrazole amide analog derivative and its microwave attenuation materials method and application | 中南民族大学 | 2019-04-05 | — | — | CN | disclosed |
| CN-205313431-U | Cyanoacetic acid ester and malonate's continuous cyaniding separator | 河北诚信九天医药化工有限公司 | 2016-06-15 | — | — | CN | disclosed |
| EP-2542531-B1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2014-09-17 | — | — | EP | disclosed |
| CN-103214395-B | Synthesizing process of 2,3-dicyanoethylpropionate | NANTONG HAISHENG PHARMACEUTICAL CO LTD | 2014-04-30 | — | — | CN | disclosed |
| CN-103214395-B | Synthesizing process of 2,3-dicyanoethylpropionate | NANTONG HAISHENG PHARMACEUTICAL CO LTD | 2014-04-30 | — | — | CN | disclosed |
| US-8507693-B2 | Process for synthesis of fipronil | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-08-13 | — | — | US | disclosed |
| CN-103214395-A | Synthesizing process of 2,3-dicyanoethylpropionate | NANTONG HAISHENG PHARMACEUTICAL CO LTD | 2013-07-24 | — | — | CN | disclosed |
| CN-103214395-A | Synthesizing process of 2,3-dicyanoethylpropionate | NANTONG HAISHENG PHARMACEUTICAL CO LTD | 2013-07-24 | — | — | CN | disclosed |
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-01-31 | — | — | US | disclosed |
| EP-2542531-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | Gharda, Keki Hormusji (IN) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011107998-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2011-09-09 | — | — | WO | disclosed |
| WO-2011086570-A1 | PROCESS FOR PREPARATION OF CYANOALKYLPROPIONATE DERIVATIVES | GHARDA KEKI HORMUSJI (IN) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | FIP1L1, CYP2F1, PFAS | SLC1A2 4068/4885CHRM1 4097/4885AKR1A1 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.